Fat dissolving injections use a synthetic form of deoxycholic acid, a bile salt your body naturally produces to break down dietary fat, to permanently destroy fat cells in targeted areas beneath the skin. The only version with FDA approval in the United States is sold under the brand name Kybella, and it is approved solely for reducing moderate-to-severe fat beneath the chin. A separate product called Aqualyx has been available in Europe since 2009. The science behind these injections is more nuanced than marketing materials suggest, and understanding how they work, what they can realistically achieve, and what can go wrong is worth the time before you book a consultation.
How the Injections Destroy Fat
Deoxycholic acid is a detergent-like molecule. When injected directly into a pocket of fat, it disrupts the membranes of fat cells, causing them to rupture and die. This process is sometimes called adipocytolysis. The contents of those destroyed cells, mostly lipids, are then gradually cleared by your body’s immune and lymphatic systems over the following weeks. Research confirms that this destruction is permanent: once a fat cell is gone, it does not regenerate.
The immune response is a feature, not a bug, but it comes with trade-offs. After injection, your body mounts an inflammatory reaction to clean up the debris from dead cells. That inflammation is responsible for the swelling, firmness, and tenderness that nearly every patient experiences. In animal models, researchers have found that this inflammation largely resolves within about four weeks after injection.
What the Clinical Evidence Shows
The strongest data exist for treating submental fat, the soft pad beneath the chin sometimes called a “double chin.” A systematic review and meta-analysis of randomized controlled trials found that patients receiving deoxycholic acid injections were roughly twice as likely to see at least a one-grade improvement in chin fullness compared to those receiving placebo, and more than five times as likely to see a two-grade improvement on clinician-rated scales.1PubMed Central. Efficacy, safety, and potential industry bias in using deoxycholic acid for submental fat reduction ‒ A systematic review and meta-analysis of randomized clinical trials A separate meta-analysis reached a similar conclusion, finding deoxycholic acid effective and safe for submental fat reduction at both the lower and higher tested doses.2PubMed. Efficacy and safety of injectable deoxycholic acid for submental fat reduction: a systematic review and meta-analysis of randomized controlled trials
In one large trial, roughly 80% of patients showed at least a one-grade improvement in submental fat about 12 weeks after their final treatment, and that improvement held at 24 weeks. Among patients receiving the active drug, 70% achieved a two-grade or greater response, compared to fewer than 19% in the placebo group.3PubMed Central. Cosmetic Bootcamp Noninvasive Submental Fat Compartment Treatment These are meaningful improvements, but they are also modest by surgical standards. If you are expecting dramatic transformation from injections alone, you may be disappointed.
Patients consistently report feeling happier and less self-conscious about their chin profile after treatment. In a phase III trial, those who received deoxycholic acid reported significantly less embarrassment, less bothered feelings, and felt they looked younger and less overweight compared to placebo recipients.4PubMed Central. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study A separate randomized trial confirmed these satisfaction findings, with a significantly greater proportion of patients treated with deoxycholic acid expressing satisfaction with the appearance of their face and chin than those who received placebo.5Journal of the American Academy of Dermatology. ATX-101 for reduction of submental fat: A phase III randomized controlled trial
What a Treatment Session Looks Like
If you picture a quick in-and-out appointment, adjust your expectations. Each session involves dozens of small injections placed in a grid pattern across the treatment area. The standard protocol uses a 1-centimeter grid applied to the skin, with each injection delivering 0.2 milliliters of the drug at a depth of roughly 6 to 10 millimeters using a very fine needle. The maximum volume per session is 10 milliliters, and the injector works from the lower part of the fat pad upward in horizontal rows.6Dermatologic Surgery. Proper Technique for Administration of ATX-101 (Deoxycholic Acid Injection): Insights From an Injection Practicum and Roundtable Discussion
Most people need two to four sessions, spaced at least a month apart, though the prescribing information allows up to six. Your provider should counsel you that results build gradually over multiple treatments and that the final outcome won’t be apparent until weeks after your last session.7PubMed Central. Novel Expanded Safe Zone for Reduction of Submental Fullness with ATX-101 Injection This is not a lunchtime procedure in any practical sense. The injection process itself takes around 15 to 20 minutes, but the recovery period after each session can interfere with your social and professional life for days or longer.
Side Effects You Should Expect
Almost everyone who gets fat dissolving injections will experience side effects at the injection site. These are not rare complications but the normal, predictable consequence of deliberately causing an inflammatory reaction in living tissue. The most common include:
- Swelling: Often the most noticeable effect, especially under the chin. Many patients describe looking like they have a bullfrog neck for several days. Moderate swelling can persist for two to four weeks.
- Bruising: Varies from person to person but common, especially given the large number of injection points per session.
- Pain and tenderness: The area feels sore, firm, and sensitive to touch for days to weeks afterward.
- Numbness: Temporary loss of sensation in the treated area occurs frequently and can last weeks or occasionally months.
- Induration: A firmness or hardness under the skin as the body processes destroyed fat cells.
Pain management typically involves taking ibuprofen or acetaminophen an hour before the procedure, along with a local anesthetic injection of lidocaine with epinephrine about 15 minutes before the deoxycholic acid goes in. Cold packs applied before or after the session can also help.
Researchers have been working on formulations that reduce these local reactions. In animal studies, deoxycholic acid packaged into slow-release microparticles significantly reduced fat without causing visible injection site reactions, because the controlled drug release dialed down the acute inflammatory burst.8GEN Biotechnology. Deoxycholate-Based Composite Microparticles for Localized Adipocytolysis That technology is not yet available clinically, but it suggests that the side-effect profile could improve in future generations of these products.
Serious Risks and Rare Complications
Beyond the expected side effects, there are real risks that deserve a frank conversation with your provider. The marginal mandibular nerve runs through the area beneath the chin, and if the injection is placed too close to it or the drug diffuses into surrounding tissue, nerve injury can occur. An animal study examining what happens when deoxycholic acid contacts nerve tissue found significant nerve damage: when the drug was injected directly into the nerve bundle, roughly 78% of the nerve area showed injury marked by scarring and fibrosis, compared to 40% in a control group that received lidocaine injection.9PubMed Central. Peripheral Nerve Injury After Deoxycholic Acid (Kybella) Injection Even when injected near the nerve rather than directly into it, almost half the nerve area was damaged. In clinical practice, nerve injury typically manifests as an asymmetric smile or difficulty with certain facial movements. It usually resolves over weeks to months, but the possibility of prolonged or permanent nerve damage exists.
The other concern is that deoxycholic acid is not selective about which cells it destroys. Laboratory research has shown that the formulation is cytotoxic to normal skin cells, endothelial cells, and muscle cells at clinical concentrations, not just fat cells.10PubMed. Actions and comparative efficacy of phosphatidylcholine formulation and isolated sodium deoxycholate for different cell types This means that injection technique matters enormously. If the drug is placed too superficially, too deeply, or in the wrong anatomical plane, it can damage skin, muscle, or other structures. Proper depth, needle placement, and adherence to the grid markings are what separate a good outcome from a complication. Chronic infection and nodule formation have also been reported, particularly with some formulations used outside the United States.11PubMed Central. Chronic Infection and Nodule Formation following Deoxycholate Injection
Who Is Actually a Good Candidate
Not everyone with fullness under the chin will benefit from fat dissolving injections. The key distinction is the source of that fullness. The strongest evidence supports treatment in patients who have localized, superficial subcutaneous fat sitting above the platysma muscle. But similar-looking fullness beneath the chin can come from several other causes: deep fat deposits below the muscle layer, skin laxity, prominent platysmal bands, enlarged salivary glands, soft tissue drooping with age, or even skeletal structure. Each of these requires a different approach, and injecting deoxycholic acid into a chin that looks full because of loose skin or prominent glands will not produce meaningful improvement.12Dermatological Reviews. Deoxycholic Acid Injection for Submental Fullness: An Anatomy‐Based Narrative Review With Considerations for Off‐Label Lower‐Face Use
This is why a thorough consultation matters more than any marketing photograph. A skilled provider will assess whether the bulge beneath your chin is pinchable fat versus deeper structural issues. If you have significant skin laxity, meaning the skin won’t snap back once the fat underneath is reduced, you may end up with loose, crepey skin that looks worse than the original fullness. Younger patients with good skin elasticity and a discrete pocket of submental fat tend to get the best results.
Are Results Permanent
Fat cells destroyed by deoxycholic acid do not come back. The drug causes permanent adipocyte ablation.13PubMed. Injectable treatments for adipose tissue: terminology, mechanism, and tissue interaction In that sense, the results are lasting. But “permanent fat cell destruction” and “permanent cosmetic result” are not quite the same thing. If you gain a substantial amount of weight after treatment, the remaining fat cells in the area can enlarge, and fat may also accumulate in adjacent areas. The treated zone will always have fewer fat cells than it originally did, so it won’t fill in the same way, but significant weight gain can still change the overall contour of your chin and neck.
There is also the matter of aging. Over time, skin loses elasticity and soft tissues descend. A chin that looked great at 35 after fat dissolving injections may look different at 55, not because the fat returned, but because the surrounding architecture changed. Maintaining results long-term is partly about maintaining a stable weight and partly about recognizing that no single treatment defeats the aging process permanently.
Kybella Versus Aqualyx and Other Formulations
Kybella is the only FDA-approved product for injectable fat reduction in the United States. In Europe, the main product is Aqualyx, a deoxycholic acid-based aqueous gel mixed with saline and buffering compounds that has been commercially available since 2009. It is the only drug approved by the European Union for localized fat reduction.11PubMed Central. Chronic Infection and Nodule Formation following Deoxycholate Injection Aqualyx uses a slightly different formulation, embedding the deoxycholic acid in a sugar-based matrix that provides slower release.14PubMed Central. Intralipotherapy, the State of the Art
You may also encounter providers using compounded mixtures of phosphatidylcholine and deoxycholic acid, sometimes called “lipo-dissolve” or “mesotherapy” cocktails. These formulations predate Kybella and Aqualyx and are not approved by any major regulatory agency for fat reduction. In animal research, these mixtures produce significant inflammation, tissue necrosis, and fibrosis.15PubMed Central. The Effect of Phosphatidylcholine and Deoxycholate Compound Injections to the Localized Adipose Tissue: An Experimental Study with a Murine Model Lab studies have shown that isolated deoxycholic acid is nearly as effective as the phosphatidylcholine combination at destroying fat cells, which is partly why the approved products dropped phosphatidylcholine from the formula.10PubMed. Actions and comparative efficacy of phosphatidylcholine formulation and isolated sodium deoxycholate for different cell types
A large case series from India treated over 1,200 patients with a phosphatidylcholine-deoxycholic acid combination across various body areas and found the best effects on the face, jawline, submental area, and upper arms, with average results on the thighs and knees.16PubMed Central. Injection Lipolysis: A Systematic Review of Literature and Our Experience with a Combination of Phosphatidylcholine and Deoxycholate over a Period of 14 Years in 1269 Patients of Indian and South East Asian Origin Those results are interesting but come with a caveat: off-label use of compounded formulations carries less regulatory oversight and more variable quality control than using an approved product for its approved indication.
Off-Label Use on Other Body Areas
One of the most common questions people have is whether these injections work on stomach fat, love handles, inner thighs, or other problem areas. Providers do use deoxycholic acid off-label in some of these locations, but the evidence base is thin compared to the chin. The FDA approval for Kybella covers only submental fat, and the controlled trials were designed and powered for that single area.
Treating larger body areas introduces practical challenges. The chin has a relatively small, well-defined pocket of fat that sits in a predictable anatomical location. Body fat is often distributed across broader, deeper, and more variable planes. The 10-milliliter maximum dose that works for the chin may be insufficient for meaningful reduction in a larger zone. And the side effects scale with the treated area: more injection points mean more swelling, more pain, and a longer recovery. For significant body contouring, procedures like liposuction or cryolipolysis remain more common choices, though each has its own trade-offs in invasiveness, cost, and downtime.
Common Misconceptions Worth Correcting
Several beliefs about fat dissolving injections circulate widely but don’t hold up to scrutiny. The first is that they are a weight-loss treatment. They are not. These injections destroy a small number of fat cells in a localized area. The amount of fat removed is cosmetically noticeable in a compact zone like the chin but metabolically trivial. You will not lose measurable weight from the procedure.
The second misconception is that results are immediate. Because the treatment works by triggering an inflammatory process that takes weeks to resolve, you will actually look worse before you look better. The swelling can be dramatic enough that some patients regret the procedure at the one-week mark, only to become satisfied once everything settles at the two-to-three-month point. Understanding this timeline in advance prevents a lot of unnecessary panic.
A third misunderstanding involves the idea that fat dissolving injections are a safer, easier alternative to liposuction with no real downside. While they avoid general anesthesia and surgical incisions, the cumulative downtime across multiple sessions can exceed the recovery from a single liposuction procedure. Some patients also assume that “non-surgical” means “risk-free,” which the nerve injury and tissue damage data clearly refute.
The Unresolved Science
Despite commercial success and FDA approval, some aspects of how deoxycholic acid works in living tissue remain incompletely understood. Researchers broadly agree on the mechanism: the drug disrupts cell membranes, fat cells die, the immune system clears the debris. But the precise downstream pathways, including how the inflammatory cascade resolves, what determines the ratio of fat reduction to fibrosis in different patients, and why some individuals respond much better than others, are still active areas of investigation. The fact that it works is well established. Exactly why it works better for some people than others, and how to optimize that, remains open territory.
There is also growing interest in whether next-generation formulations can improve the experience. The controlled-release microparticle approach mentioned earlier is one avenue. Other researchers are exploring whether combining deoxycholic acid with anti-inflammatory agents or delivering it through different mechanisms could maintain efficacy while cutting side effects. For now, though, if you are considering fat dissolving injections, you are working with the current generation of products and their known profile of real but manageable side effects, meaningful but moderate results, and permanent but limited fat destruction.